Low neutralization capacity against SARS-CoV-2 Omicron BQ.1.1 of convalescent plasma collected during circulation of Omicron BA.1
- PMID: 36897221
- DOI: 10.1111/vox.13418
Low neutralization capacity against SARS-CoV-2 Omicron BQ.1.1 of convalescent plasma collected during circulation of Omicron BA.1
References
REFERENCES
-
- Arora P, Kempf A, Nehlmeier I, Schulz SR, Jäck HM, Pöhlmann S, et al. Omicron sublineage BQ.1.1 resistance to monoclonal antibodies. Lancet Infect Dis. 2023;23:22-3.
-
- Touret F, Giraud E, Bourret J, Donati F, Tran-Rajau J, Chiaravalli J, et al. Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 Omicron sub-lineages. bioRxiv. 2022. https://doi.org/10.1101/2022.12.22.521201
-
- Gallian P, Amroun A, Laperche S, Le Cam S, Brisbarre N, Malard L, et al. Reduced neutralizing antibody potency of COVID-19 convalescent vaccinated plasma against SARS-CoV-2 Omicron variant. Vox Sang. 2022l;117:971-5.
-
- Planas D, Bruel T, Staropoli I, Guivel-Benhassine F, Porrot F, Maes P, et al. Resistance of Omicron subvariants BA.2.75.2, BA.4.6 and BQ.1.1 to neutralizing antibodies. bioRxiv. 2022 . 2022.11.17.516888. https://doi.org/10.1101/2022.11.17.516888
-
- Qu P, Evans JP, Faraone JN, Zheng YM, Carlin C, Anghelina M, et al. Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2. Cell Host Microbe. 2023;31:9-17.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
